Evaluating the effect of mutations and ligand binding on transthyretin homotetramer dynamics

Tadeo E Saldaño1, Giuseppe Zanotti2, Gustavo Parisi1

  • 1Universidad Nacional de Quilmes/CONICET, Bernal, Argentina.

Plos One
|July 14, 2017
PubMed

Insights

Transthyretin (TTR) amyloidosis is linked to mutations destabilizing its structure. Identifying key TTR positions and understanding drug interactions are crucial for stabilizing the TTR tetramer and preventing disease.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Computational Biology

Background:

  • Transthyretin (TTR) amyloidosis involves the dissociation of the native TTR homotetramer, initiating fibril formation.
  • Specific point mutations can destabilize TTR's quaternary structure, promoting amyloidogenesis.
  • Drug development for TTR amyloidosis focuses on compounds that bind to and stabilize the TTR tetramer.

Purpose of the Study:

  • To identify critical positions within the TTR tetramer that influence its dynamical stability.
  • To analyze how mutations at these positions affect TTR tetramer equilibrium dynamics.
  • To evaluate the impact of various compounds on TTR-ligand binding and tetramer stabilization.

Main Methods:

  • Normal mode analysis to assess TTR tetramer dynamics.
  • Simulation of local perturbations to study TTR response.
  • Analysis of TTR-ligand binding interactions and their effect on vibrations.

Main Results:

  • Key positions sustaining TTR tetramer stability are primarily located at β-strands E and F and the EF-loop.
  • Mutations at the monomer-monomer interface significantly alter TTR tetramer dynamics, increasing amyloidosis risk.
  • Mutations at dimer-dimer interfaces or the T4 hormone binding site also destabilize the TTR tetramer.

Conclusions:

  • The monomer-monomer interface is a vulnerable region for mutations leading to TTR amyloidosis.
  • Understanding TTR's dynamical stability and ligand interactions is vital for developing effective therapies.
  • Computational analysis provides insights into TTR stabilization mechanisms and drug efficacy.

Related Concept Videos

Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
9.1K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

2.7K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.4K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.7K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
19.8K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.4K